

MERCURY may be an impurity the following product types:
lip gloss (52)
lip liner (42)
eye liner (39)
brow liner (29)
mascara (13)
lipstick (12)
moisturizer (9)
nail treatment (2)
concealer (1)
baby soap (1)




HG; MERCURY, DISSOLVED; MERCURY, TOTAL; COLLOIDAL MERCURY; HYDRARGYRUM; KWIK (DUTCH) ; LIQUID SILVER; MERCURE (FRENCH) ; MERCURIO (ITALIAN) ; MERCURY (ACGIH:OSHA) ; MERCURY FUME


Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to this ingredient -- not the products containing it -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.
| This ingredient: | |
![]() | Cancer |
![]() | Developmental/reproductive toxicity |
![]() | Violations, restrictions & warnings |
![]() | Allergies/immunotoxicity |
![]() | Contamination concerns |
![]() | Other strong concerns for this ingredient: Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Occupational hazards |
![]() | Other moderate concerns for this ingredient: Neurotoxicity, Endocrine disruption, Biochemical or cellular level changes |
![]() | Lesser or emerging concerns for this ingredient: Ecotoxicology, Data gaps |
|
See products containing MERCURY See ingredients that may have MERCURY as an impurity See products that may have MERCURY as an impurity | |
MERCURY has reported used in the following product types: pain relief (3); eye drops/artificial tears (2)
| type of concern | product conditions | reference |
| Human skin toxicant - strong evidence | CHE Toxicant and Disease Database | |
| Human immune toxicant - moderate evidence | CHE Toxicant and Disease Database |
| type of concern | product conditions | reference |
| Violation of government restrictions - Banned or found unsafe for use in cosmetics | Japan's Standards for Cosmetics | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Restricted for use in cosmetics by the FDA (US) | U.S. - Ingredients Prohibited and Restricted in Cosmetics by FDA Regulations | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Use is restricted in Canadian cosmetics | Canada - Prohibited and Restricted Cosmetics Ingredients | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Restricted in EU cosmetics (mandatory manufacturing or structural specifications) | European Union - Banned or Restricted in Cosmetics |
| type of concern | product conditions | reference |
| Possible human developmental toxicant | California EPA Proposition 65 | |
| Human nervous system toxicant - strong evidence | CHE Toxicant and Disease Database | |
| Limited evidence of reproductive toxicity | European Union - Classification & Labelling | |
| Human reproductive toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| Human developmental toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| Human musculoskeletal toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| Human nervous system toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| Human nervous system toxicant - moderate evidence | Chemicals known to be neurotoxic to humans | |
| show more | ||
| type of concern | product conditions | reference |
| Strong evidence of human neurotoxicity | CHE Toxicant and Disease Database | |
| Strong evidence of human neurotoxicity | Chemicals known to be neurotoxic to humans | |
| show more | ||
| type of concern | product conditions | reference |
| Known human respiratory toxicant | EPA Hazardous Air Pollutants | |
| Known human renal toxicant | CHE Toxicant and Disease Database | |
| Known human respiratory toxicant | products that may be aerosolized (airborne) | CHE Toxicant and Disease Database |
| Known human sense organ toxicant | CHE Toxicant and Disease Database | |
| Possible human hematologic toxicant | CHE Toxicant and Disease Database | |
| Possible human renal toxicant | CHE Toxicant and Disease Database | |
| Possible human cardiovascular toxicant | CHE Toxicant and Disease Database | |
| Possible human respiratory toxicant | CHE Toxicant and Disease Database | |
| Classified as expected to be toxic or harmful | Environmental Canada Domestic Substance List | |
| show more | ||
| type of concern | product conditions | reference |
| Persistent, bioaccumulative in wildlife and humans | EPA Toxic Release Inventory PBTs | |
| Persistent, bioaccumulative in wildlife | Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET) | |
| Persistent, bioaccumulative in wildlife | Great Lakes BTS (Binational Toxics Strategy) PBTs | |
| Persistent, bioaccumulative in wildlife | EPA PBTs - Waste Minimization Program (RCRA) | |
| show more | ||
| type of concern | product conditions | reference |
| Allowed workplace exposures restricted to very low doses | National Library of Medicine HazMap | |
| Allowed workplace exposures restricted to very low doses | RTECS®- TLV/BEI,2006 | |
| Allowed workplace exposures restricted to very low doses | RTECS®- TLV/BEI,2007 | |
| show more | ||
| type of concern | product conditions | reference |
| Cancer - limited evidence | CHE Toxicant and Disease Database | |
| show more | ||
| type of concern | product conditions | reference |
| Limited evidence of endocrine disruption | CHE Toxicant and Disease Database | |
| show more | ||
| type of concern | product conditions | reference |
| Cancer - moderate evidence - immune system | CHE Toxicant and Disease Database |
| type of concern | product conditions | reference |
| Wildlife and environmental toxicity | European Union - Classification & Labelling | |
| show more | ||
| type of concern | product conditions | reference |
| Not assessed for safety in cosmetics by industry panel | ||
| Insufficient data to determine safety | EPA Integrated Risk Information System (IRIS) | |
| 15,919 studies on toxicity in PubMed see search results -> | PubMed |
| government/industry list/academic study | appears on list as | classification(s) |
| European Union - Classification & Labelling | MERCURY | •May be toxic to the reproductive system •Very toxic to aquatic organisms |
| U.S. - Ingredients Prohibited and Restricted in Cosmetics by FDA Regulations | MERCURY COMPOUNDS | •Restricted for use in cosmetics by the FDA (US) |
| Canada - Prohibited and Restricted Cosmetics Ingredients | MERCURY | •Use is restricted in Canadian cosmetics |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: renal system toxicity; Condition: acute tubular necrosis; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | MERCURY | ALS (Lou Gehrig's disease) - Limited |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: reproductive system toxicity; Condition: altered sex ratio; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: hematologic system toxicity; Condition: anemia (including hemolytic); Organs/tissues affected: blood |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: hematologic system toxicity; Condition: aplastic anemia; Organs/tissues affected: bone marrow |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: immune system toxicity; Condition: autoimmune antibodies (positive ANA, anti-DNA, RF, etc.); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: behavioral problems; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: nervous system toxicity; Condition: brain cancer (adult); Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: respiratory system toxicity; Condition: bronchitis - acute; Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: cerebral palsy; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: renal system toxicity; Condition: chronic renal disease; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity, developmental toxicity; Condition: cognitive impairment (includes impaired learning, impaired memory, and decreased attention span)/mental retardation/developmental delay; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: developmental toxicity; Condition: congenital malformations (birth defects); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: skin toxicity; Condition: contact dermatitis - irritant; Organs/tissues affected: skin |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: cardiovascular system toxicity; Condition: coronary artery disease, peripheral vascular disease, atherosclerosis; Organs/tissues affected: heart |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: musculoskeletal system toxicity, developmental toxicity; Condition: cranio- facial malformations; Organs/tissues affected: bone |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: decreased coordination/ dysequilibrium; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | Decreased vision (includes blindness, retinopathy, optic neuropathy) - Good |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: developmental toxicity; Condition: delayed growth; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: reproductive system toxicity; Condition: erectile dysfunction; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: reproductive system toxicity; Condition: fetotoxicity (miscarriage/spontaneous abortion, stillbirth); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: renal system toxicity; Condition: glomerulonephritis; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: sense organ system toxicity; Condition: hearing loss; Organs/tissues affected: ears |
| CHE Toxicant and Disease Database | MERCURY | Hormonal changes (levels of circulating sex hormones - FSH/LH, Inhibin, and/or estrogens, progesterones, androgens) - Limited |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: cardiovascular system toxicity; Condition: hypertension (high blood pressure); Organs/tissues affected: blood vessels |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: immune system toxicity; Condition: immune suppression; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: developmental toxicity; Condition: low birth weight/small for gestational age/intra-uterine growth retardation; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: reproductive system toxicity; Condition: menstrual disorders (abnormal bleeding, short cycles, long cycles, irregular cycles, painful periods); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: Minamata disease; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: cardiovascular system toxicity; Condition: myocardial infarction (heart attack); Organs/tissues affected: heart |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: renal system toxicity; Condition: nephrotic syndrome; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: nervous system toxicity, developmental toxicity; Condition: neural tube defects/central nervous system malformations; Organs/tissues affected: neural tube |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: nervous system; Condition: neurosthenia (organic affective syndrome); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: peripheral neuropathy; Organs/tissues affected: peripheral nervous system |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: respiratory system toxicity; Condition: pneumonia; Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: respiratory system toxicity; Condition: pneumonitis (hypersensitivity); Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: psychiatric disturbances (disorientation, hallucinations, psychosis, delirium, paranoias, anxiety/depression, emotional laibility, mood changes, euphoria).; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: respiratory system toxicity, cardiovascular system toxicity; Condition: pulmonary edema; Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: respiratory system toxicity; Condition: pulmonary fibrosis; Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: reproductive system toxicity; Condition: reduced fertility - female (infertility and subfertility); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: reproductive system toxicity; Condition: reduced fertility - male (infertility and subfertility); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: musculoskeletal system toxicity, skin toxicity; Condition: scleroderma; Organs/tissues affected: skin, connective tissue |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: seizures; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: spasticity/myoclonus; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: endocrine system toxicity; Condition: thyroid disorders - hypothyroidism; Organs/tissues affected: thyroid gland |
| EPA Clean Water Act - Priority Pollutants | MERCURY | •Priority water pollutant under the Clean Water Act |
| Environmental Canada Domestic Substance List | MERCURY | •This chemical was flagged for further attention by CEPA due to suspected aquatic toxicity and persistence. |
| Illinois EPA Chemicals Associated with Endocrine System | MERCURY | •EPA: probable endocrine disruptor |
| EPA Integrated Risk Information System (IRIS) | MERCURY, ELEMENTAL | •Group D: Not classifiable as to human carcinogenicity (EPA classification) |
| European Commission on Endocrine Disruption | MERCURY | HH-CAT3;WF-CAT3 |
| European Union - Banned or Restricted in Cosmetics | MERCURY AND ITS COMPOUNDS | •Restricted in EU cosmetics (mandatory manufacturing or structural specifications) |
| European Union - Water Framework Directive | MERCURY AND ITS COMPOUNDS | •Priority substance in EU water policy |
| EPA Hazardous Air Pollutants | MERCURY COMPOUNDS | •Hazardous air pollutant under Clean Air Act |
| National Library of Medicine HazMap | MERCURY | •Skin Designation (ACGIH) - Danger of cutaneous absorption (ACGIH): Yes; •Skin Sensitizer - An agent that can induce an allergic reaction in the skin or lungs: Yes; •Reproductive Toxin - A chemical that is toxic to the reproductive system, including defects in the progeny and injury to male and female reproductive function: Yes; •Restricted - Regulations that have banned or restricted the use of the agent: Paint manufacturers agreed to discontinued the use of mercury in exterior paints after September 1991 and in interior paints after Aug 20, 1990. [ATSDR Case Studies # 17, p. 3]; •Toxic Pneumonitis: Yes; •Nephrotoxin: Yes; •Neurotoxin: Sensorimotor Neuropathy;LC: 11 |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | MERCURY AND INORGANIC MERCURY COMPOUNDS | •IARC Group 3 (no cancer link) |
| Japan's Standards for Cosmetics | MERCURY AND ITS COMPOUNDS | •Japan - prohibited for use in cosmetics |
| Chemicals known to be neurotoxic to humans | MERCURY | •Known to be neurotoxic to humans, suspected developmental neurotoxin |
| Our Stolen Future Endocrine Disruptors | MERCURY | • |
| Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET) | MERCURY COMPOUNDS | •Persistent toxicant under Canada's Accelerated Reduction/Elimination of Toxics program - targeted for elimination or reduction |
| Great Lakes BTS (Binational Toxics Strategy) PBTs | MERCURY COMPOUNDS | •Persistent, bioaccumulative toxicant - Great Lakes Binational Strategy, Tier 1 concern (highest), targeted for phase-out |
| EPA PBTs - Waste Minimization Program (RCRA) | MERCURY | •Persistent, bioaccumulative toxicant - Resource Conservation and Recovery Act, priority chemical for voluntary waste/emission reductions |
| EPA Toxic Release Inventory PBTs | TOTALMERCURY | •Very persistent and bioaccumulative toxicant - targeted for waste reporting under U.S. Environmental Protection Agency Toxics Release Inventory programs |
| EPA Toxic Release Inventory PBTs | MERCURY COMPOUNDS | •Very persistent and bioaccumulative toxicant - targeted for waste reporting under U.S. Environmental Protection Agency Toxics Release Inventory programs |
| California EPA Proposition 65 | MERCURY AND MERCURY COMPOUNDS | •Developmental toxin: California Proposition 65 |
| US EPA, 9204 | MERCURY | •Reproductive toxicity hazards: suspected |
| A Relational Database of Hazardous Chemicals and Occupational Diseases, 1990 | MERCURY | •Respiratory toxicity hazards: suspected |
| Illinois EPA, 1997 | MERCURY | •Endocrine toxicity hazards: suspected |
| Klaassen, C, 1996 | MERCURY | •Cardiovascular or blood toxicity hazards: suspected |
| National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances, 1995 | MERCURY | •Gastrointestinal or liver toxicity hazards: suspected |
| Malachowsky, M, 1995 | MERCURY COMPOUNDS | •Cardiovascular or blood toxicity hazards: suspected |
| Proposition 65 List of Carcinogens | MERCURY COMPOUNDS | •Cancer hazards: suspected |
| RTECS®- TLV/BEI,2006 | MERCURY | • occupationally related - ACGIH TLV (human TWA) |
| RTECS®- TLV/BEI,2007 | MERCURY | • occupationally related - ACGIH TLV (human TWA) |
| RTECS®- Toxicologist 2003 | MERCURY | • mutagenic - Positive mutation assay: DNA Damage (mouse ihl) |
| RTECS®- Toxicologist 2003 | MERCURY | • mutagenic - Positive mutation assay: DNA Damage (mouse ihl) |
| RTECS®- Zeitschrift fuer Krebsforschung 1957 | MERCURY | • cancer - Tumors at site of application (rat TDLo) |
| government/industry list/academic study | reference |
| European Union - Classification & Labelling | CPS&Q (Consumer Products Safety & Quality) formely known as ECB (European Chemicals Bureau). 2008. Classification and Labelling: Chemicals: Annex I of Directive 67/548/EEC through the 31st ATP. |
| U.S. - Ingredients Prohibited and Restricted in Cosmetics by FDA Regulations | FDA (U.S. Food and Drug Administration), 2006. Ingredients Prohibited and Restricted by FDA Regulations. FDA Center for Food Safety and Applied Nutrition, Office of Cosmetics and Colors. Downloaded from http://www.cfsan.fda.gov/~dms/cos-210.html. |
| Canada - Prohibited and Restricted Cosmetics Ingredients | Health Canada. 2007. List of Prohibited and Restricted Cosmetic Ingredients. Canada's Cosmetic Ingredient Hotlist. March 2007. |
| CHE Toxicant and Disease Database | CHE (The Collaborative on Health and the Environment). 2006. Toxicant and Disease Database. |
| EPA Clean Water Act - Priority Pollutants | |
| Environmental Canada Domestic Substance List | EC (Environment Canada). 2008. Domestic Substances List Categorization. Canadian Environmental Protection Act (CEPA) Environmental Registry. |
| Illinois EPA Chemicals Associated with Endocrine System | Illinois EPA (Illinois Environmental Protection Agency). 2000. Preliminary list of chemicals associated with endocrine system effects in animals and humans (*) or in vitro (+). In EPA (U.S. Environmental Protection Agency) 2000. Handbook for Non-Cancer Health Effects Valuation, Appendix C. |
| EPA Integrated Risk Information System (IRIS) | EPA (U.S. Environmental Protection Agency). 2008. Integrated Risk Information System (IRIS). Evidence for human carcinogenicity based on 1986-2005 guidelines. |
| European Commission on Endocrine Disruption | EU (European Union)- Strategy for Endocrine Disrupters 2007. Commision on endocrin disruption requested by the European Parliament in 1998. |
| European Union - Banned or Restricted in Cosmetics | EC (European Commission of the European Union). 1999-2006. Enterprise Directorate-General Pharmaceuticals and Cosmetics. The rules governing cosmetic products in the European Union, Volume 1, "Cosmetics legislation." |
| European Union - Water Framework Directive | EU (European Union). 2000. Water Framework Directive (Directive 2000/60/EC ) - integrated river basin management for Europe. List of priority substances. |
| EPA Hazardous Air Pollutants | EPA (U.S. Environmental Protection Agency). 2005. Office of Air. The 112(b)1 Hazardous Air Pollutants List (as modified). Last modified: 12 Dec 2005. |
| National Library of Medicine HazMap | NLM (National Library of Medicine). 2006. HazMap — Occupational Exposure to Hazardous Agents. |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | IARC (International Agency for Research on Cancer). 2008. Overall Evaluations of Carcinogenicity to Humans, as evaluated in IARC Monographs Volumes 1-99 (a total of 935 agents, mixtures and exposures). |
| Japan's Standards for Cosmetics | Japan Ministry of Health, Labour and Welfare. 2006. Standards for Cosmetics. Evaluation and Licensing Division. Pharmaceutical and Food Safety Bureau. |
| Chemicals known to be neurotoxic to humans | Grandjean P and PJ Landrigan. 2006. Developmental neurotoxicity of industrial chemicals. Lancet. 2006 Dec 16;368(9553):2167-78. |
| Our Stolen Future Endocrine Disruptors | Colborn T, D Dumanoski, JP Myers. 2006. Widespread Pollutants with Endocrine-disrupting Effects. Updated from original listing in "Our Stolen Future" (1996). |
| Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET) | EC (Environment Canada). 1994. Accelerated Reduction/Elimination of Toxics (ARET). ARET substance list of persistent, bioaccumulative and toxic chemicals. |
| Great Lakes BTS (Binational Toxics Strategy) PBTs | Great Lakes BTS (Binational Toxics Strategy). 1997. Canada-United States Strategy for the Virtual Elimination of Persistent Toxic Substances in the Great Lakes. Appendix I - Level 1 and Level 2 substances. |
| EPA PBTs - Waste Minimization Program (RCRA) | EPA (U.S. Environmental Protection Agency). 1998. Resource Conservatin and Recovery Act (RCRA) Waste Minimization Program - priority chemicals for elimination or reduction. |
| EPA Toxic Release Inventory PBTs | EPA (U.S. Environmental Protection Agency). 1999. Toxics Release Inventory Program. PBT Chemical Rule. |
| California EPA Proposition 65 | California EPA (California Environmental Protection Agency). 9/2008. Office of Environmental Health Hazard Assessment. Safe Drinking Water and Toxic Enforcement Act of 1986. Chemicals known to the State to cause cancer or reproductive toxicity. |
| Scorecard.org Toxicity Information | US EPA. Roadmaps to Sources of Information on Chemicals Listed in the Emergency Planning Community and Community Right-to-Know Act (Also Known as SARA Title 3), Section 313 Toxic Release Inventory (for Microcomputers). (Report Number EPADFDK92040). 1991. Data file distributed in 2 diskettes by Office of Pollution, Prevention, and Toxics, Environmental Protection Agency, Washington, DC. NOTE: Datasource no longer being maintained by EPA; not currently available online., Frazier , L. and M. L. Hage (eds.). Reproductive Hazards of the Workplace, Wiley Europe, 1998. Table 10 (Partial List of Reproductive Toxicants) available at http://www.pharmacy.ohio-state.edu/homepage/safety/chemhygiene_table_repro.pdf., A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, California EPA, Office of Environmental Health Hazard Assessment. Acute Reference Exposure Levels (RELs), Averaging Times, and Toxicologic Endpoints. Includes all Acute Reference Exposure Levels (ARELs) developed by OEHHA through May 2000http://www.oehha.org/air/acute_rels/allAcRELs.html |
| Scorecard.org Toxicity Information | A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Nemery, B. Metal Toxicity and the Respiratory Tract. European Respiratory Journal. 3(2): 202-219. 1990.(Table 1: Summary of pulmonary toxicity of metals). |
| Scorecard.org Toxicity Information | Illinois EPA. Endocrine Disruptors Strategy. 1997. (Table 1: Preliminary List of Chemicals Associated with Endocrine System Effects in Animals and Humans or In Vitro). http://www.nihs.go.jp/hse/environ/illiepatable.htm, Keith, L.H. (ed.). Environmental Endocrine Disruptors. John Wiley & Sons, NY. 1997. http://www.wileyeurope.com/cda/product/0,,0471191450%7Cdesc%7C3037,00.html, World Wildlife Fund. Our Stolen Future. Widespread Pollutants with Endocrine-disrupting Effects. http://www.ourstolenfuture.org/Basics/chemlist.htm. The WWF list is derived from references detailed at http://www.ourstolenfuture.org/Sources/chemsources.htm and was originally published in: Colborn, T., F.S. vom Saal, and A.M. Soto. Developmental Effects of Endocrine-Disrupting Chemicals In Wildlife and Humans. Environmental Health Perspectives 101(5): 378-384. 1993. |
| Scorecard.org Toxicity Information | Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996. |
| Scorecard.org Toxicity Information | National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation., Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995. |
| Scorecard.org Toxicity Information | Malachowsky, M.J. Health Effects of Toxic Substances. Government Institutes. Rockville, MD 1995. |
| Scorecard.org Toxicity Information | Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html.-MC |
| RTECS®- TLV/BEI,2006 | RTECS®- TLV/BEI,2006 |
| RTECS®- TLV/BEI,2007 | RTECS®- TLV/BEI,2007 |
| RTECS®- Toxicologist 2003 | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- -1981 72(Supp 1),360,2003 |
| RTECS®- Toxicologist 2003 | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- 72(Supp 1),360,2003 |
| RTECS®- Zeitschrift fuer Krebsforschung 1957 | RTECS®- Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. 61,511,1957 |
"RTECS®" is a United States trademark owned and licensed under authority of the U.S. Government, by and through MDL Information Systems, Inc.
No items in basket.
Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.
We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.
Stay informed with email updates on toxics in everyday products and how they can affect your health.
Find out more about the Campaign for Safe Cosmetics.